Kitrinor Metals Inc. and Scythian Biosciences Inc. Announce Closing of Second Tranche of Subscription Receipt Financing and Common Share Offering

March 31, 2017

Responsive image

Scythian Biosciences Inc. is developing a proprietary Cannabinoid combination therapy for the prevention and treatment of concussions and traumatic brain injury

Category: General